Global Addisons Disease Treatment Market Size To Worth USD 6.02 Billion By 2033 | CAGR OF 8.93%
Category: HealthcareGlobal Addisons Disease Treatment Market Size To Worth USD 6.02 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Addison’s Disease Treatment Market Size is to Grow from USD 2.56 Billion in 2023 to USD 6.02 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 8.93% during the projected period.
Get more details on this report -
Browse key industry insights spread across 213 pages with 110 Market data tables and figures & charts from the report on the "Global Addison’s Disease Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Mineralocorticoids, Glucocorticoids, Others), By Diagnosis (Imaging Testing, Laboratory Testing), By Treatment (Oral Corticosteroids, Corticosteroid Injections), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/addisons-disease-treatment-market
Addison's disease, also known as primary adrenal insufficiency, is a rare but serious disorder where the adrenal glands fail to produce sufficient amounts of certain hormones, particularly cortisol and aldosterone. Cortisol is crucial for regulating metabolism, the immune response, and stress response, while aldosterone controls blood pressure. The most common cause is an autoimmune response, but it can also result from infections, tumors, or other conditions damaging the adrenal glands. Treatment for Addison's disease involves hormone replacement therapy, typically involving glucocorticoids or mineralocorticoids. Regular monitoring and medical supervision are essential for managing the disease and ensuring patients maintain a good quality of life. However, the daily medication burden, long-term side effects, increased risk of infections, and the need for regular medical appointments can be time-consuming and costly.
The glucocorticoids segment is anticipated to hold the greatest share of the global Addison’s disease treatment market during the projected timeframe.
Based on the drug class, the global Addison’s disease treatment market is divided into mineralocorticoids, glucocorticoids, and others. Among these, the glucocorticoids segment is anticipated to hold the greatest share of the global Addison’s disease treatment market during the projected timeframe. Glucocorticoids are rapidly growing in the treatment of Addison's disease due to their potential to replace the cortisol hormone, a key component of the disease, and their lifelong management.
The laboratory testing segment is anticipated to grow at the fastest pace in the global Addison’s disease treatment market during the projected timeframe.
Based on the diagnosis, the global Addison’s disease treatment market is divided into imaging testing and laboratory testing. Among these, the laboratory testing segment is anticipated to grow at the fastest pace in the global Addison’s disease treatment market during the projected timeframe. Laboratory tests like cortisol and ACTH are crucial for early diagnosis and treatment of Addison's disease, driven by increased awareness, improved healthcare infrastructure, and advancements in diagnostic technology.
The oral corticosteroids segment is anticipated to grow at the fastest pace in the global Addison’s disease treatment market during the projected timeframe.
Based on the treatment, the global Addison’s disease treatment market is divided into oral corticosteroids and corticosteroid injections. Among these, the oral corticosteroids segment is anticipated to grow at the fastest pace in the global Addison’s disease treatment market during the projected timeframe. Oral medications are preferred for long-term illness care due to convenience, ease of administration, and daily prescriptions for Addison's disease. Improvements in formulations increased patient adherence, and growing diagnosis cases drive growth.
North America is expected to hold the largest share of the global Addison’s disease treatment market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global Addison’s disease treatment market over the forecast period. The Addison's disease treatment market in the region is thriving due to a robust healthcare system, increased awareness, modern diagnostic tools, US pharmaceutical companies, and favorable reimbursement policies.
Asia Pacific is predicted to grow at the fastest pace in the global Addison’s disease treatment market during the projected timeframe. The Addison's disease treatment market in the region is experiencing rapid growth due to factors such as increased healthcare spending, awareness of adrenal gland disorders, and improved healthcare. The growing population and government initiatives to improve healthcare access and expand pharmaceutical services are also contributing to this growth.
Major vendors in the Global Addison’s Disease Treatment Market include Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Shire plc, Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., AbbVie Inc., Bausch Health Companies Inc., Fresenius Kabi AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Viatris Inc., Bayer AG, and Others.
Recent Developments
- In March 2023, Oregon State University College of Engineering developed a handheld sensor capable of testing perspiration for cortisol in just eight minutes, a significant advancement in hormone monitoring.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Addison’s Disease Treatment Market based on the below-mentioned segments:
Global Addison’s Disease Treatment Market, By Drug Class
- Mineralocorticoids
- Glucocorticoids
- Others
Global Addison’s Disease Treatment Market, By Diagnosis
- Imaging Testing
- Laboratory Testing
Global Addison’s Disease Treatment Market, By Treatment
- Oral Corticosteroids
- Corticosteroid Injections
Global Addison’s Disease Treatment Market, Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?